reported that an autophagy inhibitor in combination with dual ICIs, anti‐CTLA4 Ab plus anti‐PD1 Ab, protected against pancreatic cancer growth in a murine isograft model.23 The gene discussed is CTLA4; the disease is pancreatic neoplasm.